Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Keytruda ups survival in lung cancer, misses secondary target

Data shows Keytruda fails to beat BMS' Opdivo

- PMLiVE

Choosing wisely

How to make the best of emerging markets

EU flag

CHMP October meeting gives recommendations for Pfizer and MSD

But the regulatory advisors sound note ofcaution on Biogen’s Tecfidera

- PMLiVE

MRN expands operations with new senior director

Todd McGrath joins from Parexel

- PMLiVE

Valeant adds member to board of directors

President of ValueAct Capital G. Mason Morfitadded to team

- PMLiVE

Novartis’ Cosentyx on course for new European indications

CHMP recommends its approval to treat ankylosing spondylitis and psoriatic arthritis

Bristol-Myers Squibb (BMS) building

First data backs efficacy of BMS’ novel HIV drug

Could provide new treatment for those resistant to antiretroviral therapy

- PMLiVE

AZ moves a step closer to gout drug approval in US

Final verdict to be delivered in end of December

- PMLiVE

Beyond the blind spots in compliance

How to create the right culture

- PMLiVE

A winning launch-readiness strategy

So much more than templates and tick boxes is required

- PMLiVE

Roche appoints new UK general manager

Richard Erwin was previously the company's general manager for Belgium

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links